KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Equity Ratio (2016 - 2026)

Amgen has reported Equity Ratio over the past 18 years, most recently at 0.1 for Q1 2026.

  • For Q1 2026, Equity Ratio rose 43.04% year-over-year to 0.1; the TTM value through Mar 2026 reached 0.1, up 43.04%, while the annual FY2025 figure was 0.1, 49.36% up from the prior year.
  • Equity Ratio for Q1 2026 was 0.1 at Amgen, up from 0.1 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.11 in Q3 2025 and troughed at 0.02 in Q1 2022.
  • A 5-year average of 0.07 and a median of 0.07 in 2024 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: plummeted 89.63% in 2022 and later surged 289.55% in 2023.
  • Year by year, Equity Ratio stood at 0.06 in 2022, then increased by 14.1% to 0.06 in 2023, then dropped by 0.24% to 0.06 in 2024, then skyrocketed by 49.36% to 0.1 in 2025, then increased by 3.94% to 0.1 in 2026.
  • Business Quant data shows Equity Ratio for AMGN at 0.1 in Q1 2026, 0.1 in Q4 2025, and 0.11 in Q3 2025.